Try our beta test site
1 study found for:    17192396 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study
Condition: Chronic Myeloid Leukemia
Intervention: Drug: Imatinib/Nilotinib

Study has passed its completion date and status has not been verified in more than two years.